Related Experiment Video
Updated: Aug 11, 2026
10:46
Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells
Published on: July 16, 2013
Effects of gap junction blockers on human neocortical synchronization
S Gigout1, J Louvel, H Kawasaki
1INSERM U 573, Paris, 75014 France.
Neurobiology of Disease
|February 16, 2006
Summary
Gap junctions synchronize human neocortical networks. Blocking these junctions reduced synchronous events in epilepsy patients and altered activity in focal cortical dysplasia, suggesting a role in epileptiform activity.
Area of Science:
- Neuroscience
- Epileptology
- Cellular Electrophysiology
Background:
- Neuronal network synchronization is crucial for brain function.
- Gap junctions (GJ) are implicated in neuronal communication and network synchronization.
- Understanding GJ role in human epilepsy is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the role of gap junctions in synchronizing human neocortical networks.
- To examine the effects of GJ blockers on spontaneous and evoked neuronal activity in epilepsy models.
- To determine if GJ contribute to epileptiform activity in focal cortical dysplasia (FCD).
Main Methods:
- Field potential and intracellular recordings from human neocortical slices.
- Application of GJ blockers (carbenoxolone, octanol, quinine, quinidine).
- Use of 4-aminopyridine (4AP) and glutamatergic receptor antagonists to induce synchronous events.
Main Results:
- GJ blockers decreased synchronicity of spontaneous events in epileptic neocortical slices.
- GJ blockers abolished or slowed down spontaneous discharges in focal cortical dysplasia (FCD) slices.
- Octanol and carbenoxolone blocked 4AP-induced ictal-like discharges in FCD slices.
Conclusions:
- Gap junctions play a significant role in synchronizing human neocortical networks.
- GJ may contribute to the generation and propagation of epileptiform activity, particularly in FCD.
- Targeting GJ could be a potential therapeutic strategy for certain epilepsy types.
Related Concept Videos
01:25Overview of Synapses
A synapse is a specialized structure where two neurons connect, allowing them to pass an electrical or chemical signal to another neuron. It is the point of communication between neurons. The term "synapse" is derived from the Greek word "synapsis," which means "conjunction." The entire process of neural communication revolves around the synapse. When activated, a neuron releases chemicals known as neurotransmitters into the synapse. These neurotransmitters cross the synapse and bind to...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:28Electrical Synapses
Electrical synapses found in all nervous systems play important and unique roles. In these synapses, the presynaptic and postsynaptic membranes are very close together (3.5 nm) and are actually physically connected by channel proteins forming gap junctions.
Gap junctions allow the current to pass directly from one cell to the next. In contrast, in the chemical synapse, the neurotransmitters carry the information through the synaptic cleft from one neuron to the next. They consist of two...
Gap junctions allow the current to pass directly from one cell to the next. In contrast, in the chemical synapse, the neurotransmitters carry the information through the synaptic cleft from one neuron to the next. They consist of two...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...